Os melhores médicos de Mamografia no exterior — Página 5

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

O Professor Moshe Papa chefia o Departamento de Cirurgia Mamária no Centro Médico Assuta. Ele é um especialista sênior que fornece interpretação especializada de mamografias para casos complexos.

• Mastologista líder focado na detecção precoce do câncer de mama
• Chefia a equipe cirúrgica no maior hospital privado de Israel
• Especializado em diagnóstico por imagem para cuidados oncológicos mamários

Ahn Jin Seok é oncologista médico no Samsung Medical Center. Ele trabalha com ferramentas de diagnóstico avançadas para detectar e tratar o câncer de mama.

• Atua no Samsung Medical Center – um hospital de primeira linha na Coreia do Sul
• Foca em oncologia, onde a mamografia é usada para o rastreamento precoce do câncer
• Especializado em cuidados oncológicos para pacientes que precisam de resultados de imagem precisos

O Dr. Seung Jae Huh é um oncologista especialista no Samsung Medical Center. Ele trabalha em uma instituição médica de alto nível, conhecida pelo seu departamento de diagnóstico avançado.

• Atua no Samsung Medical Center – um hospital líder em rastreamento e tratamento de câncer
• Integra os resultados da mamografia em planos abrangentes de cuidados oncológicos
• Colabora com equipes multidisciplinares para garantir a interpretação precisa de imagens mamárias

O Dr. Emre Günenç é especialista em Cirurgia Plástica, Reconstrutiva e Estética no İstinye University Liv Hospital Topkapı, onde atua desde 2026. Realizou a sua formação no Hospital de Treino e Investigação Prof. Dr. Cemil Taşcıoğlu, um dos maiores e mais movimentados centros de Istambul, o que lhe proporcionou uma vasta experiência cirúrgica.

Formação: Universidade Acıbadem. Residência em Cirurgia Plástica no Hospital de Treino e Investigação Prof. Dr. Cemil Taşcıoğlu. Cargos de especialista: Hospital de Treino e Investigação Gazi Yaşargil (2024–2025) e Hospital de Treino e Investigação Cemil Taşcıoğlu (2024).

Acreditações: Membro da Associação Turca de Cirurgia Plástica, Reconstrutiva e Estética. Cursos: 42.º Curso Básico de Microcirurgia, ISAPS 5th Aesthetic Istanbul e 4th Full Circle Rhinoplasty Live Surgery. Participou ainda em diversos congressos nacionais e em cursos focados em rinoplastia e estética facial. Foco: resultados naturais, equilibrados e funcionais em rinoplastia, bem como em procedimentos mamários, corporais e faciais.

O Dr. Raanan Berger é o diretor do Centro de Câncer do Sheba Medical Center. Ele foi incluído na lista de "Melhores Médicos" da Forbes Israel em 2025. O Dr. Berger é especializado em oncologia geniturinária e trata tumores complexos de próstata com radioterapia. Ele completou um pós-doutorado no Dana-Farber/Harvard Cancer Institute.

• Chefia a unidade de pesquisa clínica focada em oncologia molecular.
• Coautor de mais de 20 artigos revisados por pares sobre câncer de próstata e mutações BRCA.
• Membro da Sociedade Americana de Oncologia Clínica (ASCO).
• Realiza terapia sistêmica e radioterapia em um hospital classificado entre os 10 melhores do mundo.

O médico é um especialista com experiência na sua área. Ele dedica-se a prestar cuidados clínicos de alta qualidade e a manter os padrões profissionais na prática médica.

O médico é um radiologista altamente versátil com vasta experiência em uma ampla gama de modalidades de imagem diagnóstica e intervencionista. A proficiência clínica inclui radiologia abdominal, Doppler, obstétrica, mamária, musculoesquelética, pediátrica e neurorradiologia, garantindo suporte diagnóstico abrangente para diversas populações de pacientes.

Além da imagem diagnóstica, o médico é qualificado na realização de procedimentos intervencionistas não vasculares, fornecendo soluções minimamente invasivas para condições clínicas complexas. Essa abordagem multidisciplinar permite precisão diagnóstica exata e intervenção terapêutica eficaz em várias especialidades médicas.

O médico é um radiologista experiente com um vasto histórico clínico em múltiplas instituições médicas. A sua carreira profissional inclui cargos na clínica de radiologia da Universidade Erciyes de Kayseri e no Hospital Estatal de Kayseri, bem como funções em diversos centros médicos privados, incluindo o Academy Medical Center, o Anaclinic Medical Center e a clínica de radiologia do Hospital Liman.

Com uma carreira focada em diagnóstico por imagem, o médico prestou serviços radiológicos no centro médico privado Samsun Private Midiliv e, mais recentemente, no hospital Samsun Büyük Anadolu. O médico possui uma experiência abrangente em radiologia clínica, contribuindo para a precisão diagnóstica e o atendimento ao paciente em diversos ambientes de saúde.

O Dr. Pasichnyk é um cirurgião plástico experiente e membro da Associação Pan-Ucraniana de Cirurgiões Reconstrutivos, Estéticos e Plásticos. É especialista em rinoplastia, blefaroplastia, otoplastia, abdominoplastia e mamoplastia, tendo trabalhado em vários hospitais por toda a Ucrânia. Possui diploma em medicina geral pela Academia Médica Estatal de Dnipropetrovsk e completou um estágio em cirurgia.

A Dra. Ani Meloyan é uma cirurgiã de rinoplastia altamente conceituada na Ucrânia, especializada em blefaroplastia, cirurgia de nariz, otoplastia, mamoplastia e lipoaspiração. Ela é membro da Sociedade Ucraniana de Cirurgiões Plásticos Estéticos (USAPS) e da Associação Armênia de Cirurgiões Plásticos e Reconstrutivos Estéticos (APRAS). Ela possui vasta experiência em cirurgia plástica e é formada pela Universidade Médica Nacional de Kharkiv e pela Universidade Médica Estadual de Yerevan.

A Dra. Brenda Pastrana é cirurgiã oncológica no Hospital Galenia em Cancún, acreditado pela JCI. Especializa-se em cânceres de mama, tireoide e sistema digestivo. A Dra. Pastrana é certificada pelo CONACEM. Possui diploma de medicina pela Universidad Autónoma de México.

• Realiza mastectomias, ressecções hepáticas e cirurgias complexas de câncer de cólon.
• Trata pacientes em uma instalação com Status Diamante da Accreditation Canada.
• Atua como professora universitária na Universidad Anáhuac.
• Membro da Sociedade Mexicana de Oncologia (SMEO).

O Dr. Burak Ergun Tatar é cirurgião plástico no Hospital Medipol Acibadem em Istambul. Especializa-se em cirurgias cosméticas e reconstrutivas transformadoras, incluindo lifting facial, rinoplastia e aumento de mama. O Dr. Tatar completou uma bolsa de microcirurgia na Università Campus Bio-Medico em Roma. Graduou-se com distinção na Faculdade de Medicina da Universidade de Istambul.

• Possui certificações especializadas em microcirurgia, pesquisa animal e estatística médica.
• Realiza contorno corporal complexo, como abdominoplastia, lipoaspiração e "mommy makeovers".
• Trata condições funcionais e estéticas, incluindo desvio de septo e ginecomastia.
• Trabalha em uma instalação credenciada pela JCI usando o sistema robótico da Vinci.

O Dr. Kunter Erten realizou mais de 1.200 procedimentos cirúrgicos bem-sucedidos. Ele pratica no Estetik International em Istambul, um centro com mais de 528.000 cirurgias realizadas. O Dr. Erten é especializado em cirurgia estética, plástica e reconstrutiva. Ele possui uma bolsa ISAPS, um programa de treinamento especializado para cirurgiões estéticos.

• Membro da Sociedade Internacional de Cirurgia Plástica Estética (ISAPS).
• Realiza procedimentos complexos, incluindo lifting facial profundo (deep plane facelift) e lipoaspiração Vaser.
• Especializado em cirurgia plástica facial, reconstrução mamária e contorno corporal.
• Membro ativo da Sociedade Turca de Cirurgiões Plásticos, Reconstrutivos e Estéticos.

O Dr. Oguz Boyraz é cirurgião plástico e reconstrutivo no Hospital Privado Çevre em Istambul. Especializa-se numa vasta gama de procedimentos estéticos, incluindo rinoplastia e contorno corporal. O Dr. Boyraz publicou pesquisas sobre reconstrução complexa pós-queimaduras e viabilidade de retalhos. Trabalha numa unidade certificada pela ISO que trata mais de 4.300 pacientes anualmente.

• Realiza mommy makeovers, BBL e lipoaspiração Vaser.
• Especialista em técnicas reconstrutivas para neoplasias do lábio inferior e deformidades auriculares.
• Apresentou pesquisas sobre técnicas cirúrgicas modificadas em vários congressos nacionais da TPRECD.
• Trata pacientes numa clínica que possui certificado de autorização de turismo de saúde internacional.